• 1. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 2. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555
• 3. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 4. Fast synthesis of copper nanoclusters through the use of hydrogen peroxide additive and their application for the fluorescence detection of Hg2+ in water samples?
  Liao Xiaoqing,Li Ruiyi,Li Zaijun,Sun Xiulan,Wang Zhouping,Liu Junkang New J. Chem., 2015,39, 5240-5248
• 5. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147

Introduction to 2-(bromomethyl)-1-iodo-4-methylbenzene (CAS No. 1178576-91-4)

2-(bromomethyl)-1-iodo-4-methylbenzene, identified by the Chemical Abstracts Service Number (CAS No.) 1178576-91-4, is a significant intermediate in the field of organic synthesis and pharmaceutical chemistry. This compound, featuring a benzene ring substituted with a bromomethyl group at the 2-position and an iodo group at the 1-position, along with a methyl group at the 4-position, exhibits unique reactivity that makes it valuable for constructing more complex molecular architectures.

The structural motif of 2-(bromomethyl)-1-iodo-4-methylbenzene positions it as a versatile building block for the synthesis of various pharmacologically relevant molecules. The presence of both bromomethyl and iodo substituents allows for selective functionalization, enabling chemists to introduce diverse functional groups through nucleophilic substitution reactions. This dual reactivity has been exploited in the development of novel therapeutic agents, particularly in the realm of medicinal chemistry where precision and modularity are paramount.

In recent years, the demand for specialized intermediates like 2-(bromomethyl)-1-iodo-4-methylbenzene has surged due to advancements in drug discovery methodologies. The compound's ability to serve as a precursor for heterocyclic compounds, which are prevalent in modern pharmaceuticals, has made it a subject of interest in academic and industrial research. For instance, studies have demonstrated its utility in constructing benzothiophene derivatives, which are known for their biological activity across multiple therapeutic areas.

One notable application of 2-(bromomethyl)-1-iodo-4-methylbenzene is in the synthesis of kinase inhibitors. Kinases are enzymes that play a crucial role in cell signaling pathways, and their dysregulation is often associated with diseases such as cancer. By leveraging the compound's reactive sites, researchers have been able to develop inhibitors that target specific kinases with high selectivity. These inhibitors have shown promise in preclinical studies, highlighting the importance of 2-(bromomethyl)-1-iodo-4-methylbenzene as a key intermediate in this context.

The pharmaceutical industry has also explored the use of 2-(bromomethyl)-1-iodo-4-methylbenzene in the development of antimicrobial agents. The structural features of this compound allow for modifications that can enhance binding affinity to bacterial enzymes or receptors. Recent research has focused on its role in creating novel antibiotics that address emerging resistant strains. The ability to introduce various functional groups via its reactive sites has been instrumental in tailoring compounds with improved efficacy and reduced side effects.

From a synthetic chemistry perspective, 2-(bromomethyl)-1-iodo-4-methylbenzene exemplifies the strategic use of halogenated aromatics in multi-step syntheses. The bromomethyl group can be readily converted into other functionalities such as alcohols or amines, while the iodo group serves as a versatile handle for cross-coupling reactions like Suzuki or Stille couplings. These transformations have been harnessed to create complex molecular frameworks essential for drug development.

The versatility of 2-(bromomethyl)-1-iodo-4-methylbenzene extends beyond pharmaceutical applications. It has found utility in materials science, particularly in the synthesis of organic semiconductors and liquid crystals. The ability to modify its structure allows researchers to fine-tune electronic properties, making it a valuable precursor for advanced materials used in electronic devices.

In conclusion, 2-(bromomethyl)-1-iodo-4-methylbenzene (CAS No. 1178576-91-4) is a multifaceted compound with broad applications across multiple scientific disciplines. Its unique structural features and reactivity make it an indispensable tool for synthetic chemists and pharmaceutical researchers alike. As research continues to uncover new methodologies and applications, the importance of this intermediate is expected to grow further, solidifying its role as a cornerstone in modern chemical synthesis.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)